Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating subcutaneous Sibeprenlimab in Sjögren's syndrome; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Sibeprenlimab

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Sjogren Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING